Tag: signing

Astellas Pharma, MD Anderson sign option agreement to research and develop new treatment for AML

| April 6, 2015 | 0 Comments

Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML).

Continue Reading

Oncodesign has entered into a services agreement with Eisai to develop a new personalized medicine program in earlier …

| December 17, 2014 | 0 Comments

ONCODESIGN , a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight cancer and other serious illnesses with no known effective treatment, announced today the signing of an agreement with Eisai Inc.

Continue Reading

Former So. Tier congressman a key leader in cancer fight

| July 19, 2013 | 0 Comments

Newspapers across the nation last month published stories commemorating the 100th anniversary of the American Cancer Society. Many featured a photo of an event President Nixon hoped would be remembered as “the most significant action taken during my Administration” — the signing of the National Cancer Act on Dec. 23, 1971.

Continue Reading